tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Emmanuel Papadakis, 30 are a SELL (24.59%), 45 are a HOLD (36.89%), 47 are a BUY (38.52%).
Analyst Emmanuel Papadakis, currently employed at DEUTSCHE BANK, carries an average stock price target met ratio of 65.61% that have a potential upside of 35.48% achieved within 198 days.
Emmanuel Papadakis’s has documented 225 price targets and ratings displayed on 16 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NVO, Novo Nordisk A/S at 23-Feb-2026.
Analyst best performing recommendations are on MRNA (MODERNA).
The best stock recommendation documented was for NVO (NOVO NORDISK A/S) at 8/3/2021. The price target of $45.67 was fulfilled within 1 day with a profit of $2.31 (5.33%) receiving and performance score of 53.27.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 01-Apr-2019
$105
$-89.22 (-45.94%)
$95
3 months 3 days ago
(09-Dec-2025)
0/13 (0%)
$-74.1 (-41.37%)
Buy Since 05-Sep-2023
$108.5
$-85.72 (-44.14%)
$88
3 months 15 days ago
(25-Nov-2025)
1/5 (20%)
$-79.22 (-42.20%)
482
Buy Since 12-Jul-2023
4 months 13 days ago
(27-Oct-2025)
6/6 (100%)
$12.74 (9.80%)
216
Buy Since 27-Jan-2020
$87
$-107.22 (-55.21%)
$78
1 years 3 months 22 days ago
(18-Nov-2024)
0/9 (0%)
$-34.46 (-28.37%)
Buy Since 05-Jan-2023
$88
$-106.22 (-54.69%)
$89
1 years 3 months 27 days ago
(13-Nov-2024)
0/7 (0%)
$-37.08 (-29.65%)
Which stock is Emmanuel Papadakis is most bullish on?
What Year was the first public recommendation made by Emmanuel Papadakis?
